Terms: = Kidney tumors AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12
536 results:
1. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.
Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X
BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348
[TBL] [Abstract] [Full Text] [Related]
2. Anastomosing haemangioma of adrenal gland: an unusual vascular tumour.
Rewari H; Wadhwa P; Talwar H; Taneja D
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38670570
[TBL] [Abstract] [Full Text] [Related]
3. Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas.
Roskoski R
Pharmacol Res; 2024 May; 203():107181. PubMed ID: 38614375
[TBL] [Abstract] [Full Text] [Related]
4. Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.
Montemagno C; Jacquel A; Pandiani C; Rastoin O; Dawaliby R; Schmitt T; Bourgoin M; Palenzuela H; Rossi AL; Ambrosetti D; Durivault J; Luciano F; Borchiellini D; Le Du J; Gonçalves LCP; Auberger P; Benhida R; Kinget L; Beuselinck B; Ronco C; Pagès G; Dufies M
J Exp Clin Cancer Res; 2024 Mar; 43(1):86. PubMed ID: 38504270
[TBL] [Abstract] [Full Text] [Related]
5. Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses.
Hameed Y
J Cancer Res Ther; 2023 Oct; 19(7):1852-1864. PubMed ID: 38376289
[TBL] [Abstract] [Full Text] [Related]
6. Toxicity Tolerance in the Carcinogenesis of Environmental Cadmium.
Cirovic A; Satarug S
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339129
[TBL] [Abstract] [Full Text] [Related]
7. Recurrent Cushing's Disease Caused by a TPIT-Lineage Densely Granulated Corticotroph Pituitary Neuroendocrine Tumor: A Case Report.
Wu W; Fu X; Guo W; Chen H
Neuro Endocrinol Lett; 2024 Jan; 45(1):76-80. PubMed ID: 38295430
[TBL] [Abstract] [Full Text] [Related]
8. Single-cell combined bioinformatics analysis: construction of immune cluster and risk prognostic model in kidney renal clear cells based on CD8
Gao H; Sun H; He A; Liu H; Zhang Z; Li D; Mao W; Qian J
Eur J Med Res; 2024 Jan; 29(1):89. PubMed ID: 38291496
[TBL] [Abstract] [Full Text] [Related]
9. Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer.
Chang H; Marquez J; Chen BK; Kim DM; Cheng ML; Liu EV; Yang H; Zhang L; Sinha M; Cheung A; Kwek SS; Chow ED; Bridge M; Aggarwal RR; Friedlander TW; Small EJ; Anderson M; Fong L
Cancer Immunol Res; 2024 Apr; 12(4):453-461. PubMed ID: 38276989
[TBL] [Abstract] [Full Text] [Related]
10. Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis.
Landré T; Karaboué A; Buchwald ZS; Innominato PF; Qian DC; Assié JB; Chouaïd C; Lévi F; Duchemann B
ESMO Open; 2024 Feb; 9(2):102220. PubMed ID: 38232612
[TBL] [Abstract] [Full Text] [Related]
11. Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma.
Singla N; Nirschl TR; Obradovic AZ; Shenderov E; Lombardo K; Liu X; Pons A; Zarif JC; Rowe SP; Trock BJ; Hammers HJ; Bivalacqua TJ; Pierorazio PM; Deutsch JS; Lotan TL; Taube JM; Ged YMA; Gorin MA; Allaf ME; Drake CG
Sci Rep; 2024 Jan; 14(1):1458. PubMed ID: 38228729
[TBL] [Abstract] [Full Text] [Related]
12. Systematic Multiomic Analysis of
Kang JY; Yang J; Lee H; Park S; Gil M; Kim KE
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203530
[TBL] [Abstract] [Full Text] [Related]
13. Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma.
Meng L; Collier KA; Wang P; Li Z; Monk P; Mortazavi A; Hu Z; Spakowicz D; Zheng L; Yang Y
Cells; 2023 Dec; 13(1):. PubMed ID: 38201238
[TBL] [Abstract] [Full Text] [Related]
14. Pyroptosis-Related Subtypes Predict the Response of Clear Cell Renal Cell Carcinoma to Targeted Therapy.
Ma J; Kang Z; Yang G; Wang X; Si M; Wang Y; Li G; Bai S; Zeng F; Li M; Wang Z; Wang L; Xu W
Front Biosci (Landmark Ed); 2023 Dec; 28(12):334. PubMed ID: 38179741
[TBL] [Abstract] [Full Text] [Related]
15. Microwave-assisted UV digestion of starch and skimmed milk powder: Environmentally friendly protocol for essential and toxic elements determination.
Ramos do Nascimento V; Pereira de Almeida D; Giacobe K; Marlon de Moraes Flores E; Augusto Bizzi C
Talanta; 2024 Apr; 270():125575. PubMed ID: 38159353
[TBL] [Abstract] [Full Text] [Related]
16. Immune checkpoint inhibitors and cancer immunotherapy by aptamers: an overview.
Kejamurthy P; Devi KTR
Med Oncol; 2023 Dec; 41(1):40. PubMed ID: 38158454
[TBL] [Abstract] [Full Text] [Related]
17. Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD.
Mae SI; Hattanda F; Morita H; Nozaki A; Katagiri N; Ogawa H; Teranaka K; Nishimura Y; Kudoh A; Yamanaka S; Matsuse K; Ryosaka M; Watanabe A; Soga T; Nishio S; Osafune K
Cell Rep; 2023 Dec; 42(12):113431. PubMed ID: 38039961
[TBL] [Abstract] [Full Text] [Related]
18. Pancreatic resection for metastasis from renal cell carcinoma: A single institution experience and meta-analysis of survival outcomes.
Hajibandeh S; Hajibandeh S; Romman S; Ghassemi N; Evans D; Laing RW; Durkin D; Athwal TS
Pancreatology; 2024 Feb; 24(1):160-168. PubMed ID: 38012888
[TBL] [Abstract] [Full Text] [Related]
19. Knockdown of ADAM8 inhibits the proliferation, migration, invasion, and tumorigenesis of renal clear cell carcinoma cells to enhance the immunotherapy efficacy.
Qu H; Mao M; Wang K; Mu Z; Hu B
Transl Res; 2024 Apr; 266():32-48. PubMed ID: 37992987
[TBL] [Abstract] [Full Text] [Related]
20. A pan-cancer analysis of the MAPK family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Qin YY; Yang Y; Ren YH; Gao F; Wang MJ; Li G; Liu YX; Fan L
Medicine (Baltimore); 2023 Nov; 102(45):e35829. PubMed ID: 37960824
[TBL] [Abstract] [Full Text] [Related]
[Next]
